Announcement on Progress in Material Asset Reorganization
Filed with SSE · · 4 pages · Chinese
Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jiangsu Aidea Pharmaceutical
- Announcement on Voluntary Disclosure of Notice of Approval for Drug Clinical Trial Application Obtained by ACC085 Injection
- Announcement on Remuneration Plan for Directors and Senior Management Members for 2026
- Announcement on Cancellation of Special Settlement Accounts for Some Raised Fund Financial Products
- Announcement on Voluntary Disclosure of Obtained Patent Certificates in Japan
- Announcement on Penalties or Regulatory Measures Imposed by Securities Regulatory Authorities and Stock Exchanges in the Recent Five Years
Later from Jiangsu Aidea Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Progress in Acquisition of Minority Shareholders' Stock Rights of a Holding Subsidiary
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Re-signing Tripartite Agreement on Supervision over Deposit in Special Account of Raised Funds after Changing Sponsor Institution
- Announcement on Voluntary Disclosure of Receipt of Approval Notice for the Listing Application of Darunavir Active Pharmaceutical Ingredient
Follow Jiangsu Aidea Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Aidea Pharmaceutical